Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
detroit blog main
detroit top stories
4
×
fda
life sciences
national blog main
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
boston top stories
cancer
deerfield management
europe blog main
europe top stories
gilead sciences
ipo
melinta therapeutics
startups
venture capital
What
medicines
4
×
fda
bio
covid
drug
ipo
new
nod
roundup
acquisitions
activity
amgen
announced
approval
approvals
approved
biogen
candidates
ceo
cholesterol
clamped
class
collabs
combo
daniel
deal
delays
developed
developing
economic
esperion
esperion’s
fast
gets
gilead
gilead’s
head
help
including
introduce
Language
unset
Current search:
medicines
×
biotech
×
" detroit top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
